Oncotelic Therapeutics Statistics
Total Valuation
OTLC has a market cap or net worth of 42.81 million. The enterprise value is 55.30 million.
| Market Cap | 42.81M |
| Enterprise Value | 55.30M |
Important Dates
The last earnings date was Thursday, November 13, 2025.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OTLC has 440.78 million shares outstanding. The number of shares has increased by 5.73% in one year.
| Current Share Class | 440.78M |
| Shares Outstanding | 440.78M |
| Shares Change (YoY) | +5.73% |
| Shares Change (QoQ) | -5.82% |
| Owned by Insiders (%) | 44.35% |
| Owned by Institutions (%) | n/a |
| Float | 225.20M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 5.30 |
| P/TBV Ratio | 6.84 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -33.13 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.08, with a Debt / Equity ratio of 1.72.
| Current Ratio | 0.08 |
| Quick Ratio | 0.02 |
| Debt / Equity | 1.72 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.82 |
Financial Efficiency
Return on equity (ROE) is -23.72% and return on invested capital (ROIC) is -2.00%.
| Return on Equity (ROE) | -23.72% |
| Return on Assets (ROA) | -1.57% |
| Return on Invested Capital (ROIC) | -2.00% |
| Return on Capital Employed (ROCE) | -8.54% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -64,198 |
| Employee Count | 26 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +228.24% in the last 52 weeks. The beta is -0.76, so OTLC's price volatility has been lower than the market average.
| Beta (5Y) | -0.76 |
| 52-Week Price Change | +228.24% |
| 50-Day Moving Average | 0.09 |
| 200-Day Moving Average | 0.06 |
| Relative Strength Index (RSI) | 53.27 |
| Average Volume (20 Days) | 255,910 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.11 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -689,493 |
| Pretax Income | -1.92M |
| Net Income | -1.67M |
| EBITDA | n/a |
| EBIT | -689,493 |
| Earnings Per Share (EPS) | -0.00 |
Balance Sheet
The company has 409,000 in cash and 13.87 million in debt, giving a net cash position of -13.46 million or -0.03 per share.
| Cash & Cash Equivalents | 409,000 |
| Total Debt | 13.87M |
| Net Cash | -13.46M |
| Net Cash Per Share | -0.03 |
| Equity (Book Value) | 8.08M |
| Book Value Per Share | 0.02 |
| Working Capital | -18.47M |
Cash Flow
| Operating Cash Flow | -704,008 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OTLC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.73% |
| Shareholder Yield | -5.73% |
| Earnings Yield | -3.90% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |